1. Therapeutic significance and the mechanism of action of the LHRH agonist ICI 118630 in breast and prostate cancer;Nicholson;J. steroid Biochem. 20,1984
2. Use and mechanism of action of the LHRH agonist ICI 118630 in the therapy of hormone sensitive breast and prostate cancer;Nicholson;Proceedings of 2nd International Congress of Hormones and Cancer,1985
3. The endocrinological evaluation of bilateral and unilateral oophorectomy in premenopausal women;Beksac;Int. J. Fert,1983
4. The hormonal activity of the post-menopausal ovary;Vermeulen;J. clin. Endocr. Metab,1976
5. Treatment with a luteinizing-hormone-releasing-hormone analogue (Buserelin) in premenopausal patients with metastatic breast cancer;Klijn;Lancet 1,1982